FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapyShruti Menon(Memorial Sloan Kettering Cancer Center), Asmin Tulpule(Memorial Sloan Kettering Cancer Center)bioRxiv (Cold Spring Harbor Laboratory)May 1, 202310.1101/2023.04.30.538578Cited by 5SaveCiteExport RISWatch citationsRelated PapersFET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy|Cancer Research|2026|0